215 related articles for article (PubMed ID: 19237648)
41. Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis in Brazil.
Rodrigues Vde F; Telles MA; Ribeiro MO; Cafrune PI; Rossetti ML; Zaha A
Antimicrob Agents Chemother; 2005 Jan; 49(1):444-6. PubMed ID: 15616332
[TBL] [Abstract][Full Text] [Related]
42. Functional analysis of the Mycobacterium tuberculosis FAD-dependent thymidylate synthase, ThyX, reveals new amino acid residues contributing to an extended ThyX motif.
Ulmer JE; Boum Y; Thouvenel CD; Myllykallio H; Sibley CH
J Bacteriol; 2008 Mar; 190(6):2056-64. PubMed ID: 18192395
[TBL] [Abstract][Full Text] [Related]
43. Minor contribution of mutations at iniA codon 501 and embC-embA intergenic region in ethambutol-resistant clinical Mycobacterium tuberculosis isolates in Kuwait.
Jaber AA; Ahmad S; Mokaddas E
Ann Clin Microbiol Antimicrob; 2009 Jan; 8():2. PubMed ID: 19146672
[TBL] [Abstract][Full Text] [Related]
44. The Dual-Targeting Activity of the Metabolite Substrate of Para-amino Salicyclic Acid in the Mycobacterial Folate Pathway: Atomistic and Structural Perspectives.
Agoni C; Ramharack P; Salifu EY; Soliman MES
Protein J; 2020 Apr; 39(2):106-117. PubMed ID: 32086691
[TBL] [Abstract][Full Text] [Related]
45. Novel katG mutations causing isoniazid resistance in clinical M. tuberculosis isolates.
Torres JN; Paul LV; Rodwell TC; Victor TC; Amallraja AM; Elghraoui A; Goodmanson AP; Ramirez-Busby SM; Chawla A; Zadorozhny V; Streicher EM; Sirgel FA; Catanzaro D; Rodrigues C; Gler MT; Crudu V; Catanzaro A; Valafar F
Emerg Microbes Infect; 2015 Jul; 4(7):e42. PubMed ID: 26251830
[TBL] [Abstract][Full Text] [Related]
46. A novel resistance mutation in eccC5 of the ESX-5 secretion system confers ofloxacin resistance in Mycobacterium tuberculosis.
Eilertson B; Maruri F; Blackman A; Guo Y; Herrera M; van der Heijden Y; Shyr Y; Sterling TR
J Antimicrob Chemother; 2016 Sep; 71(9):2419-27. PubMed ID: 27261264
[TBL] [Abstract][Full Text] [Related]
47. Transfer of embB codon 306 mutations into clinical Mycobacterium tuberculosis strains alters susceptibility to ethambutol, isoniazid, and rifampin.
Safi H; Sayers B; Hazbón MH; Alland D
Antimicrob Agents Chemother; 2008 Jun; 52(6):2027-34. PubMed ID: 18378710
[TBL] [Abstract][Full Text] [Related]
48. Synthesis and evaluation of C-5 modified 2'-deoxyuridine monophosphates as inhibitors of M. tuberculosis thymidylate synthase.
Alexandrova LA; Chekhov VO; Shmalenyuk ER; Kochetkov SN; El-Asrar RA; Herdewijn P
Bioorg Med Chem; 2015 Nov; 23(22):7131-7. PubMed ID: 26482569
[TBL] [Abstract][Full Text] [Related]
49. Analysis of gene mutations associated with isoniazid, rifampicin and ethambutol resistance among Mycobacterium tuberculosis isolates from Ethiopia.
Tessema B; Beer J; Emmrich F; Sack U; Rodloff AC
BMC Infect Dis; 2012 Feb; 12():37. PubMed ID: 22325147
[TBL] [Abstract][Full Text] [Related]
50. Mutations at embB codon 306 are an important molecular indicator of ethambutol resistance in Mycobacterium tuberculosis.
Starks AM; Gumusboga A; Plikaytis BB; Shinnick TM; Posey JE
Antimicrob Agents Chemother; 2009 Mar; 53(3):1061-6. PubMed ID: 19104018
[TBL] [Abstract][Full Text] [Related]
51. Genotypic and phenotypic characterization of Mycobacterium tuberculosis resistance against fluoroquinolones in the northeast of Iran.
Sayadi M; Zare H; Jamedar SA; Hashemy SI; Meshkat Z; Soleimanpour S; Hoffner S; Ghazvini K
BMC Infect Dis; 2020 Jun; 20(1):390. PubMed ID: 32487030
[TBL] [Abstract][Full Text] [Related]
52. ubiA (Rv3806c) encoding DPPR synthase involved in cell wall synthesis is associated with ethambutol resistance in Mycobacterium tuberculosis.
He L; Wang X; Cui P; Jin J; Chen J; Zhang W; Zhang Y
Tuberculosis (Edinb); 2015 Mar; 95(2):149-54. PubMed ID: 25547657
[TBL] [Abstract][Full Text] [Related]
53. Kinetics and ligand-binding preferences of Mycobacterium tuberculosis thymidylate synthases, ThyA and ThyX.
Hunter JH; Gujjar R; Pang CK; Rathod PK
PLoS One; 2008 May; 3(5):e2237. PubMed ID: 18493582
[TBL] [Abstract][Full Text] [Related]
54. Molecular analysis of pyrazinamide resistance in Mycobacterium tuberculosis in Vietnam highlights the high rate of pyrazinamide resistance-associated mutations in clinical isolates.
Huy NQ; Lucie C; Hoa TTT; Hung NV; Lan NTN; Son NT; Nhung NV; Anh DD; Anne-Laure B; Van Anh NT
Emerg Microbes Infect; 2017 Oct; 6(10):e86. PubMed ID: 29018250
[TBL] [Abstract][Full Text] [Related]
55. Genome-wide DNA methylation and transcriptome and proteome changes in Mycobacterium tuberculosis with para-aminosalicylic acid resistance.
Li HC; Chen T; Yu L; Guo HX; Chen L; Chen YH; Chen M; Zhao J; Yan HM; Zhou L; Wang W
Chem Biol Drug Des; 2020 Jan; 95(1):104-112. PubMed ID: 31562690
[TBL] [Abstract][Full Text] [Related]
56. Molecular identification of mutations associated with anti-tuberculosis drug resistance among strains of Mycobacterium tuberculosis.
Abbadi SH; Sameaa GA; Morlock G; Cooksey RC
Int J Infect Dis; 2009 Nov; 13(6):673-8. PubMed ID: 19138546
[TBL] [Abstract][Full Text] [Related]
57. Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.
Al-Mutairi NM; Ahmad S; Mokaddas E; Eldeen HS; Joseph S
BMC Infect Dis; 2019 Jan; 19(1):3. PubMed ID: 30606116
[TBL] [Abstract][Full Text] [Related]
58. Absence of hybridization with the wild-type and mutant rpoB probes in the Genotype MTBDRplus assay detects 'disputed' rifampicin mutations.
Abanda NN; Djieugoué JY; Khadka VS; Pefura-Yone EW; Mbacham WF; Vernet G; Penlap VM; Deng Y; Eyangoh SI; Taylor DW; Leke RGF
Clin Microbiol Infect; 2018 Jul; 24(7):781.e1-781.e3. PubMed ID: 29217277
[TBL] [Abstract][Full Text] [Related]
59. Mechanisms of resistance against NITD-916, a direct inhibitor of Mycobacterium tuberculosis InhA.
McNeil MB; Dennison D; Shelton C; Flint L; Korkegian A; Parish T
Tuberculosis (Edinb); 2017 Dec; 107():133-136. PubMed ID: 29050761
[TBL] [Abstract][Full Text] [Related]
60. Genotypic analysis of isoniazid and rifampin resistance in drug-resistant clinical Mycobacterium tuberculosis complex isolates in southern Turkey.
Aslan G; Tezcan S; Serin MS; Emekdas G
Jpn J Infect Dis; 2008 Jul; 61(4):255-60. PubMed ID: 18653964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
